Anzeige
Mehr »
Samstag, 20.06.2026 - Börsentäglich über 12.000 News
Quantum X Labs: Steigt die Aktie auch durch das Amazon-AWS-Fieber?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
526 Leser
Artikel bewerten:
(2)

Alliance Family of Companies Rebrands Itself Stratus

Name Change Better Reflects the Company's Neurodiagnostic and EEG Solutions

DALLAS, TX / ACCESSWIRE / December 23, 2019 / Alliance Family of Companies, the nation's leading provider of in-home neurodiagnostic testing services, announces it will consolidate all of its brands under the Stratus name. The new single Stratus name will simplify the brand in the marketplace and better represent the full range of services and solutions they provide.

The company launched its new comprehensive brand at the American Epilepsy Society's 2019 Annual Meeting in Baltimore, Dec. 6-10.

Stratus will continue to provide physicians and patients the same range of services as provided under previous brands. During the past several years, the company has expanded its offerings to provide a number of tools that support neurodiagnostic testing in the neurology and epilepsy communities. In particular, in 2018 the company established majority ownership in Stratus Software Solutions to improve the quality and access of data for the remote monitoring and reading of EEG diagnostic tests. The company's cloud-based software is also designed to support and enable EEG monitoring requirements that will take effect Jan. 1, 2020.

"Alliance Family of Companies has continued to evolve from its roots as Respiratory Sleep Solutions, which was formed in 2006," said J. Randall Keene, chairman and chief executive officer of Stratus. "Since then, we have grown to offer a variety of other neurology-focused services that were each represented under a different brand name. For simplification, now all of our company brands will be known as Stratus."

"We are proud to be the market leader who has served more than 53,000 patients and thousands of physicians across the United States. While Stratus is a new name for our company, we will continue our focus and dedication on being the trusted leader in neurodiagnostic services known for quality, exceptional patient care, responsiveness and innovation."

Benefits of in-home neurodiagnostic services

The core service of Stratus has been its in-home, ambulatory video EEG service. Stratus' software, hardware and monitoring services allow patients the privacy, convenience and comfort of video EEG testing in their own home. Backed by research, the quality and diagnostic accuracy of an in-home video EEG study can be similar to that of an inpatient diagnostic evaluation at an epilepsy monitoring unit in a hospital or health care facility. In-home video EEG is significantly less expensive than inpatient video EEG. And Stratus provides the ordering physician a diagnostic report within days of the study's completion.

In addition, Stratus provides home sleep studies and mobile cardiac telemetry testing to aid physicians in obtaining all the information they may need to make an accurate diagnosis.

"From the inception of our company, Stratus has been committed to innovation in order to ensure outstanding patient care, access to our services and affordable costs," said Jeremy Slater, M.D., chief medical officer of Stratus. "Those things check all the boxes for insurance providers, physicians and patients alike, and we believe they reflect our desire to reduce the patient care cycle, improve clinical outcomes and to constantly lead and improve the industry as a whole."

For more information on Stratus, please visit www.stratusneuro.com.

About Stratus

Stratus provides neurodiagnostic testing solutions and technologies that serve to expedite patient diagnoses and care, enabling physicians to improve patients' quality of life. Services provided include routine EEG services and long-term video-monitored EEG studies in the inpatient, ambulatory and in-home settings. The company also provides secure, cloud-based EEG software and technology that offers on-demand access and review software that allows physicians to read an EEG from any location with internet access, at any time of day or night. Additionally, Stratus provides mobile cardiac telemetry and sleep studies to support the diagnostic testing needs of the neurology community. To learn more, visit www.stratusneuro.com.

Media Contact for Stratus:

Jo Trizila, TrizCom PR
Office: 972-247-1369 | Cell/Text: 214-232-0078 | Email: Jo@TrizCom.com

SOURCE: Stratus



View source version on accesswire.com:
https://www.accesswire.com/571231/Alliance-Family-of-Companies-Rebrands-Itself-Stratus

© 2019 ACCESS Newswire
SpaceX-Hype zu teuer – Diese 5 Aktien bieten bessere Chancen
Raumfahrt-Aktien gehören aktuell zu den heißesten Wetten an den Börsen. Spätestens mit dem spektakulären Börsengang von SpaceX ist der Sektor endgültig im Fokus der Anleger angekommen. Fantasien rund um Satellitenkommunikation, Rechenzentren im All und neue Geschäftsmodelle treiben die Kurse immer weiter nach oben.

Doch während die Begeisterung steigt, werden auch die Risiken größer. Viele Space-Start-ups sind inzwischen extrem hoch bewertet, arbeiten noch nicht profitabel und hängen stark von stetigem Kapitalzufluss ab. Schon kleine Rückschläge könnten die ambitionierten Wachstumspläne ins Wanken bringen.

Für Anleger, die vom Boom der Raumfahrt profitieren wollen, lohnt sich daher ein Perspektivwechsel. Statt auf überhitzte Pure Plays zu setzen, rücken etablierte Konzerne in den Fokus – Unternehmen mit jahrzehntelanger Erfahrung, stabilen Cashflows und engen Verbindungen zu Raumfahrtagenturen wie NASA und ESA.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau dieses Profil erfüllen: solide bewertet, operativ stark und bestens positioniert, um langfristig vom Space-Boom zu profitieren.

Jetzt den kostenlosen Report sichern – bevor der Markt die versteckten Gewinner entdeckt!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.